Nicole J Boczek1, Dan Ye1, Fang Jin1, David J Tester1, April Huseby1, J Martijn Bos1, Aaron J Johnson1, Ronald Kanter1, Michael J Ackerman2. 1. From the Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory (N.J.B., D.Y., D.J.T., J.M.B., M.J.A.), Division of Immunology and Neurology (F.J., A.H., A.J.J.), and Departments of Medicine (Division of Cardiovascular Diseases) and Pediatrics (Division of Pediatric Cardiology) (M.J.A.), Mayo Clinic, Rochester, MN; Division of Cardiology, Nicklaus Children's Hospital, Miami, FL (R.K.). 2. From the Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory (N.J.B., D.Y., D.J.T., J.M.B., M.J.A.), Division of Immunology and Neurology (F.J., A.H., A.J.J.), and Departments of Medicine (Division of Cardiovascular Diseases) and Pediatrics (Division of Pediatric Cardiology) (M.J.A.), Mayo Clinic, Rochester, MN; Division of Cardiology, Nicklaus Children's Hospital, Miami, FL (R.K.). ackerman.michael@mayo.edu.
Abstract
BACKGROUND: A portion of sudden cardiac deaths can be attributed to structural heart diseases, such as hypertrophic cardiomyopathy (HCM) or cardiac channelopathies such as long-QT syndrome (LQTS); however, the underlying molecular mechanisms are distinct. Here, we identify a novel CACNA1C missense mutation with mixed loss-of-function/gain-of-function responsible for a complex phenotype of LQTS, HCM, sudden cardiac death, and congenital heart defects. METHODS AND RESULTS: Whole exome sequencing in combination with Ingenuity variant analysis was completed on 3 affected individuals and 1 unaffected individual from a large pedigree with concomitant LQTS, HCM, and congenital heart defects and identified a novel CACNA1C mutation, p.Arg518Cys, as the most likely candidate mutation. Mutational analysis of exon 12 of CACNA1C was completed on 5 additional patients with a similar phenotype of LQTS plus a personal or family history of HCM-like phenotypes and identified 2 additional pedigrees with mutations at the same position, p.Arg518Cys/His. Whole cell patch clamp technique was used to assess the electrophysiological effects of the identified mutations in CaV1.2 and revealed a complex phenotype, including loss of current density and inactivation in combination with increased window and late current. CONCLUSIONS: Through whole exome sequencing and expanded cohort screening, we identified a novel genetic substrate p.Arg518Cys/His-CACNA1C, in patients with a complex phenotype including LQTS, HCM, and congenital heart defects annotated as cardiac-only Timothy syndrome. Our electrophysiological studies, identification of mutations at the same amino acid position in multiple pedigrees, and cosegregation with disease in these pedigrees provide evidence that p.Arg518Cys/His is the pathogenic substrate for the observed phenotype.
BACKGROUND: A portion of sudden cardiac deaths can be attributed to structural heart diseases, such as hypertrophic cardiomyopathy (HCM) or cardiac channelopathies such as long-QT syndrome (LQTS); however, the underlying molecular mechanisms are distinct. Here, we identify a novel CACNA1C missense mutation with mixed loss-of-function/gain-of-function responsible for a complex phenotype of LQTS, HCM, sudden cardiac death, and congenital heart defects. METHODS AND RESULTS: Whole exome sequencing in combination with Ingenuity variant analysis was completed on 3 affected individuals and 1 unaffected individual from a large pedigree with concomitant LQTS, HCM, and congenital heart defects and identified a novel CACNA1C mutation, p.Arg518Cys, as the most likely candidate mutation. Mutational analysis of exon 12 of CACNA1C was completed on 5 additional patients with a similar phenotype of LQTS plus a personal or family history of HCM-like phenotypes and identified 2 additional pedigrees with mutations at the same position, p.Arg518Cys/His. Whole cell patch clamp technique was used to assess the electrophysiological effects of the identified mutations in CaV1.2 and revealed a complex phenotype, including loss of current density and inactivation in combination with increased window and late current. CONCLUSIONS: Through whole exome sequencing and expanded cohort screening, we identified a novel genetic substrate p.Arg518Cys/His-CACNA1C, in patients with a complex phenotype including LQTS, HCM, and congenital heart defects annotated as cardiac-only Timothy syndrome. Our electrophysiological studies, identification of mutations at the same amino acid position in multiple pedigrees, and cosegregation with disease in these pedigrees provide evidence that p.Arg518Cys/His is the pathogenic substrate for the observed phenotype.
Authors: Nicole J Boczek; Jabe M Best; David J Tester; John R Giudicessi; Sumit Middha; Jared M Evans; Timothy J Kamp; Michael J Ackerman Journal: Circ Cardiovasc Genet Date: 2013-06
Authors: Elena Burashnikov; Ryan Pfeiffer; Héctor Barajas-Martinez; Eva Delpón; Dan Hu; Mayurika Desai; Martin Borggrefe; Michel Häissaguerre; Ronald Kanter; Guido D Pollevick; Alejandra Guerchicoff; Ruben Laiño; Mark Marieb; Koonlawee Nademanee; Gi-Byoung Nam; Roberto Robles; Rainer Schimpf; Dwight D Stapleton; Sami Viskin; Stephen Winters; Christian Wolpert; Samuel Zimmern; Christian Veltmann; Charles Antzelevitch Journal: Heart Rhythm Date: 2010-10-14 Impact factor: 6.343
Authors: Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young Journal: Circulation Date: 2006-03-27 Impact factor: 29.690
Authors: Sebastian Fröhler; Moritz Kieslich; Claudia Langnick; Mirjam Feldkamp; Bernd Opgen-Rhein; Felix Berger; Joachim C Will; Wei Chen Journal: BMC Med Genet Date: 2014-04-29 Impact factor: 2.103
Authors: Lu Han; Yang Li; Jason Tchao; Aaron D Kaplan; Bo Lin; You Li; Jocelyn Mich-Basso; Agnieszka Lis; Narmeen Hassan; Barry London; Glenna C L Bett; Kimimasa Tobita; Randall L Rasmusson; Lei Yang Journal: Cardiovasc Res Date: 2014-09-10 Impact factor: 10.787
Authors: Worawan B Limpitikul; Ivy E Dick; David J Tester; Nicole J Boczek; Pattraranee Limphong; Wanjun Yang; Myoung Hyun Choi; Jennifer Babich; Deborah DiSilvestre; Ronald J Kanter; Gordon F Tomaselli; Michael J Ackerman; David T Yue Journal: Circ Res Date: 2016-10-20 Impact factor: 17.367
Authors: Moradeke A Bamgboye; Kevin G Herold; Daiana C O Vieira; Maria K Traficante; Philippa J Rogers; Manu Ben-Johny; Ivy E Dick Journal: J Gen Physiol Date: 2022-09-27 Impact factor: 4.000
Authors: Lindsey Gakenheimer-Smith; Lindsay Meyers; Derek Lundahl; Shaji C Menon; T Jared Bunch; Briana L Sawyer; Martin Tristani-Firouzi; Susan P Etheridge Journal: Mol Genet Genomic Med Date: 2021-04-01 Impact factor: 2.183